A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06955988 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: AST2303 Tablets(ABK3376 Tablets) ，25mg
DRUG: AST2303 Tablets(ABK3376 Tablets) ，50mg
DRUG: AST2303 Tablets(ABK3376 Tablets) ，75mg
DRUG: AST2303 Tablets(ABK3376 Tablets) ，100mg
DRUG: AST2303 Tablets(ABK3376 Tablets) ，125mg

Sponsor

Allist Pharmaceuticals, Inc.